Aptevo Therapeutics Inc. Banner Image

Aptevo Therapeutics Inc.

  • Ticker APVO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Aptevo Therapeutics Inc. Logo Image
  • 51-200 Employees
  • Based in Seattle, Washington
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The Company's lead clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed based on the Company's versatile and robust ADAPTIRâ„¢ modular protein technology platform. The ADAPTIR platform is capable of generatingMore highly differentiated bispecific antibodies with unique mechanisms of action for the treatment of different types of cancer
4.8 / 5.0 (134)

Aptevo Therapeutics Inc. reports have an aggregate usefulness score of 4.8 based on 134 reviews.

Aptevo Therapeutics Inc.

Most Recent Annual Report

Aptevo Therapeutics Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Aptevo Therapeutics Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!